Skip to content
AnalystLens

Brookfield Asset Management Ltd. 8-K Report, Regulation FD Disclosure (Oct 14, 2025)

Reports
Regulation FD·Other Events·Exhibits & Filings
Filing Date
Filed October 14, 2025
Period End
October 13, 2025
Security
BAM
In the record · 2022–202610-K410-Q58-K133

BAM filed 4 annual reports (10-K), 5 quarterly reports (10-Q) and 133 current reports (8-K) between 2022 and 2026.

  1. Deal closed8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed October 14, 2025. Cited figures are marked; the original filing is the authoritative source.

On October 13, 2025, Brookfield Asset Management Ltd. (BAM) and Brookfield Corporation (BN) agreed to acquire the roughly 26%a interest in Oaktree Capital that Brookfield does not already own, bringing Oaktree to 100% Brookfield ownership.

Total consideration is approximately $3 billionb, with BAM funding about $1.6 billion and BN about $1.4 billion, in line with their current proportional ownership. Oaktree common equity holders may elect cash, BAM Class A Limited Voting Shares, or, subject to limitations, BN shares, with BAM and BN shares subject to two-year and five-year lock-ups respectively. For BAM investors, the deal gives BAM an incremental 26% of Oaktree's fee-related earnings, carried interest from certain funds (net of BN's 33% royalty), and partner manager interests in 17Capital and DoubleLine.

Management states that BAM generated about $2.8 billionc of fee-related earnings over the last twelve months including 100% of Oaktree, and that the transaction is expected to be accretive to both BAM and BN. Both companies intend to repurchase shares corresponding to the amount issued, which management says should have little to no dilutive impact, with BN offering to supply BAM shares from its holdings, subject to regulatory approval. The transaction is expected to close in the first quarter of 2026, subject to regulatory approvals and customary closing conditions.

Management also highlights that the deal makes the U.S. BAM's largest market, with more than 50%d of employees and about 50% of revenue expected to be U.S.-based upon completion. The filing itself offers limited quantitative detail on accretion, valuation multiples, or the exact share count, so investors should review the forthcoming definitive documentation and regulatory filings for those specifics.

02—Key points

Key Highlights

  1. Brookfield agreed to acquire the ~26% of Oaktree it does not own for approximately $3 billion, giving 100% ownership of Oaktree.
  2. BAM funds ~$1.6 billion and BN ~$1.4 billion, reflecting their current proportional interests in Oaktree.
  3. BAM gains an incremental 26% of Oaktree's fee-related earnings, carried interest from certain funds (net of BN's 33% royalty), and partner manager interests in 17Capital and DoubleLine.
  4. Oaktree holders can elect cash, BAM Class A shares, or subject to limits, BN shares; BAM shares carry a two-year lock-up and BN shares a five-year lock-up.
  5. Management expects the deal to be accretive to both BAM and BN, with BAM and BN intending to repurchase shares issued to limit dilution.
  6. BAM's pro forma FRE was about $2.8 billion over the last twelve months, and the U.S. becomes its largest market with ~50% of revenue and >50% of employees.
  7. Closing is expected in Q1 2026, subject to regulatory approvals and customary conditions; Oaktree had $209 billion AUM as of June 30, 2025.

03—Questions

Frequently Asked Questions

  1. How much will Brookfield pay for the remaining Oaktree stake?

    Total consideration for the remaining common equity interests is approximately $3 billion. BAM will fund about $1.6 billion and BN about $1.4 billion, reflecting their current proportional ownership of Oaktree.

  2. What does BAM actually receive in the transaction?

    BAM acquires an incremental 26% interest in Oaktree's fee-related earnings, carried interest from certain funds (net of BN's 33% royalty), and partner manager interests in 17Capital and DoubleLine. BN receives the balance-sheet investments and remaining carried interest.

  3. Will the deal dilute existing BAM shareholders?

    Management says the impact should be minimal. BAM intends to buy back shares equal to the number issued, either on the open market or, subject to regulatory approval, from BN, which has agreed to make shares available.

  4. When is the transaction expected to close and what could delay it?

    Closing is expected in the first quarter of 2026. It is subject to regulatory approvals and customary closing conditions, which are not detailed in this filing.

  5. Are there lock-up restrictions on shares Oaktree holders receive?

    Yes. BAM shares issued as consideration are subject to a two-year lock-up, and BN shares are subject to a five-year lock-up, which limits when recipients can sell.

04—Continue

← View all 8-K filings